PubMed Health⌕ Search

Biomedical subjects

P Weismüller

Publications and source records attributed to P Weismüller.

At least 19 recordsLinked to original sources

[A 66-year old female patient with tachycardia and syncope].

A 66-year old female patient suffered from paroxysmal tachycardias, palpitations, dizziness and once a short period of unconsciousness. The surface ECG showed preexcitation, and the clinical diagnosis of WPW syndrome was established. The electrophysiological study revealed the rare occurrence of an epicardial posteroseptal accessory pathway. Retrograde venous angiography of the coronary sinus showed a coronary sinus diverticulum. Ablation of the accessory pathway in the neck of the coronary sinus diverticulum was successful. Epicardial accessory pathways in a coronary sinus diverticulum are rare. However, successful ablation of accessory pathways at this site is safely possible.

Aged↗

Multiple AV nodal pathways in patients with AV nodal reentrant tachycardia--more common than expected?

AIMS: It was the purpose of this study to determine the incidence of more than two AV nodal pathways in patients with AVNRT. METHODS AND RESULTS: In 78 consecutive patients with AV-nodal reentrant tachycardias (AVNRT) (50 females, 28 males, mean age 52.8 +/- 14.6 years), the number of sudden AH increases by 50 ms or more (AH-jump) was analysed during atrial extrastimulation. The incidence of two AV nodal pathways was accepted to be present in patients with AVNRT without an AH-jump ('smooth curve'). The following forms of tachycardia were induced: a typical AVNRT (slow-fast) in 67 patients, an atypical AVNRT (fast-slow) in 12 patients and a slow-slow-AVNRT in 4 patients. Five patients had two forms of AVNRT. 47 patients (60.3%) showed two AV nodal pathways, 27 patients (34.6%) had three AV-nodal pathways and 4 patients (5.1%) exhibited four AV-nodal pathways. For successful catheter ablation of AVNRT in patients with more than two pathways, more radiofrequency energy applications were required (9.2 +/- 6.3) compared with patients with only two pathways (6.7 +/- 4.8). Furthermore, in patients with more than two AV-nodal pathways, the catheter intervention resulted more frequently in a modulation of slow pathway conduction than in an ablation of the slow pathway(s). CONCLUSION: The incidence of more than two AV-nodal pathways in patients with AVNRT was unexpectedly high at about 40%. Thus, these tachycardias require a meticulous electrophysiological evaluation for successful ablation.

Adolescent↗

[Current aspects of defibrillator therapy in congestive heart failure].

The beneficial effects of implantable cardioverter defibrillator (ICD) therapy in patients (pts) with life-threatening ventricular tachyarrhythmias and impaired left ventricular (LV) function is still unclear. We studied the follow-up of 410 pts (368 males, 42 females, mean age 57 +/- 11 years) after ICD implant. The LV function was assessed by the New York Heart Association functional class of heart failure (NYHA). Fifty pts (12%) were in NYHA I-II, 151 pts (37%) in NYHA II, 117 pts (29%) in NYHA II-III and 92 pts (22%) in NYHA III. Epicardial ICD implantation was performed in 209 pts (51%) and 201 pts (49%) received nonthoracotomy ICDs. Perioperatively (within 30 days after implant), 12 pts (3%) died, significantly more frequent after epicardial (11 of 209 pts, 5%) than after transvenous ICD implant (1 of 201 pts, < 1%) (p < 0.05). During a mean follow-up of 28 +/- 24 months (range < 1 to 114 months), 90 pts (23%) died: 9 pts (2%) died from sudden arrhythmic death and 5 pts (1%) suddenly, but probably not from arrhythmic causes; 55 pts (14%) died from cardiac causes (congestive heart failure, myocardial reinfarction) and 21 pts (5%) from noncardiac causes. The 3-year, 5-year and 7-year survival was 92% to 96% for arrhythmic mortality in NYHA class I, II and III compared to the 3-year survival of 94%, and a 5-year and 7-year survival of 84% in patients with NYHA class II-III. 338 pts (82%) received ICD shocks (mean incidence 21 +/- 43 shocks per pt); pts in NYHA class II (83%), class II-III (84%), class III (90%) received ICD discharges significantly more frequently than in class I-II (64%) (p < 0.05). Our data show that pts with LV dysfunction benefit from ICD therapy and that these pts survive for a considerable time after the first shock. However, survival is clearly influenced by the degree of left ventricular dysfunction and, in addition to ICD therapy, aggressive treatment of heart failure is necessary.

Aged↗

AV nodal pathways in the R-R interval histogram of the 24-hour monitoring ECG in patients with atrial fibrillation.

BACKGROUND: Patients with more than one AV nodal pathway show two and more peaks in the histogram of the R-R intervals of the Holter monitoring ECG during atrial fibrillation. It was the purpose of the present study to determine the number of patients showing more than one AV nodal pathway in a larger patient group with permanent atrial fibrillation by analyzing the Holter monitoring ECG. METHODS: 250 patients with permanent atrial fibrillation during Holter monitoring ECG were studied; 203 patients had structural heart disease. The number of peaks in the R-R interval histogram of each patient was determined. The distribution of the number of peaks in the R-R interval histogram in different patient groups was analyzed. RESULTS: 153 patients (61%) had one peak, 80 patients (32%) two peaks, 13 patients (5%) three peaks, and four patients (2%) four peaks, reflecting the number of different AV nodal pathways. In the different patient groups, in the patients with or without structural heart disease, with coronary heart disease, with a history of syncope, and in patients with a mean heart rate of more than 100/min, there was no significant difference in the distribution of the number of peaks in the R-R interval histogram. CONCLUSIONS: In more than one third of all patients with permanent atrial fibrillation there are two, three, or four AV nodal pathways. It is suggested that this number of different AV nodal pathways found in the studied group can be applied to all humans. 38.8% of all patients with permanent atrial fibrillation have more than one AV nodal pathway; 6.4% of all patients with atrial fibrillation would benefit from an ablation of AV nodal pathways with shorter refractory periods for reduction of the heart rate.

Adult↗

[Terminating supraventricular tachycardia with adenosine--comparing the effectiveness of 12 mg and 18 mg].

OBJECTIVES: This study was done to answer the question if intravenous application of 18 mg adenosine is superior to 12 mg adenosine for the termination of supraventricular tachycardias. PATIENTS AND METHODS: 31 patients (17 men, 14 women, mean age 53 +/- 15 years [range 15-76 years]) had electrophysiological tests. In 25 patients AV nodal reentrant tachycardias were induced during programmed stimulation, 6 patients had inducible AV reentrant tachycardias with an accessory pathway. After induction of the supraventricular tachycardia (mean rate 183 +/- 29/minute, range 115-240/minute), in each patient 12 or 18 mg adenosine was applied in a bolus for terminating of the tachycardia. After the second induction of the tachycardia, a dose of 18 or 12 mg adenosine was given. The different doses of adenosine were chosen in a randomized and prospective manner in a crossover design. RESULTS: In 25 of the 31 patients (81%) the tachycardia was terminated by 12 mg adenosine. In 29 of the 31 patients (94%) the induced tachycardia was terminated by the application of 18 mg adenosine (no significant difference). In one patient, the tachycardia cessation was observed after 12 mg adenosine, but not after 18 mg adenosine. In another patient the tachycardia was not terminated by either 12 mg or by 18 mg adenosine. The termination of the tachycardia was seen after 25 +/- 8 seconds (13-51 seconds) when 12 mg adenosine was given. After the application of 18 mg adenosine the tachycardia ended after 25 +/- 8 seconds (14-44 seconds) (not significant). The asystole directly after tachycardia termination was 976 +/- 63 milliseconds (540-1700 milliseconds) with 12 mg adenosine, and 1070 +/- 628 milliseconds (530-4000 milliseconds) after the application of 18 mg adenosine (not significant). The longest asystole after termination of a tachycardia by 18 mg adenosine was 9.03 seconds. In one patient the tachycardia was reinitiated by spontaneous atrial extrasystoles after 12 mg adenosine, and reinduction of tachycardia was seen twice after 18 mg adenosine. After the administration of 18 mg adenosine, atrial fibrillation was observed in one patient. No serious complication occurred. CONCLUSIONS: In AV nodal reentrant tachycardias and AV reentrant tachycardias with an accessory pathway, which can not be terminated by the administration of adenosine in a dose of 12 mg, the tachycardia can be terminated more effectively by the application of 18 mg adenosine.

Adenosine↗

Uncoupling of ATP-sensitive potassium current from cell metabolism due to antisense oligonucleotides against sulfonylurea receptor in guinea-pig atrial myocytes.

ATP-sensitive K+ current (IK(ATP)) plays an important role in the regulation of cardiac electrical activity. In the myocardium, IK(ATP) is regulated by the sulfonylurea receptor (SURIIA) which mediates the inhibition of IK(ATP) due to glibenclamide (Gli). The role played by SURIIA in the sensitivity of IK(ATP) to metabolic inhibition is unclear. We studied the effect of SURIIA antisense oligonucleotides (ODNs) on the properties of IK(ATP) in cultured guinea-pig atrial myocytes. IK(ATP) was measured by the whole-cell voltage clamp method and was activated with cromakalim (Cro; 200 microns) and dinitrophenole (DNP; 100 microns). Mean IK(ATP) density activated by DNP and Cro in nonincubated cells was 117 +/- 12 pA/pF (n = 17) and 17 +/- 9 pA/pF (n = 16) respectively. No significant difference was observed after incubation with nODN [DNP: 121 +/- 13 pA/pF (n = 20); Cro:19 +/- 4 pA/pF (n = 8)]. Cells incubated with ODNs showed a significant reduction of IK(ATP) due to DNP (19 +/- 13 pA/pF; P < 0.05, n = 6), whereas Cro-induced IK(ATP) was unaffected (16 +/- 8 pA/pF, n = 8). The effectiveness of DNP-induced metabolic inhibition was apparent in a concomitant reduction of the nucleotide-phosphate dependent muscarinic K+ current (inhibition of IK(ACh) in ODN incubated myocytes without activation of IK(ATP)). The ATP sensitivity of IK(ATP) appears mediated by SURIIA. Activation of this current by Cro seems to be SURIIA-independent. ODN-induced metabolic uncoupling of IK(ATP) may be a useful experimental tool. A reduced sensitivity of IK(ATP) to intracellular ATP concentrations may be of clinical interest.

2,4-Dinitrophenol↗

Multiple AV nodal pathways with multiple peaks in the RR interval histogram of the Holter monitoring ECG during atrial fibrillation.

Two or more peaks on the 24-hour electrocardiogram (ECG) RR interval histogram of patients with atrial fibrillation suggests the presence multiple AV nodal pathways. The prevalence of multiple AV nodal pathways in this population is unknown. The study included 250 patients with permanent atrial fibrillation during 24-hour ECG. The number of peaks on the RR interval histogram was measured in each patient. A single peak was present in 153 patients (61%), 80 patients (32%) had two peaks, 13 patients (5%) had three, and 4 patients (2%) had four peaks. Among the 97 patients (39%) with > 1 AV nodal pathway, the estimated mean heart rate reduction by hypothetical ablation of all supernumerary AV nodal pathways with short refractory periods was 16 beats/min, from 82 to 65 beats/min. Among the overall population, 16 patients (6%) with > 1 AV nodal pathway had a mean heart rate > 100 beats/min. In this subgroup, modulation of AV node conduction by hypothetical ablation of all supernumerary AV nodal pathways with short refractory periods yielded an estimated reduction in mean heart rate of 26 +/- 15 beats/min, from 110 +/- 9 beats/min to 84 +/- 14 beats/min (P < 0.01), a 23% decrease. The presence of > 1 AV nodal pathway was suspected in 39% of all patients with permanent atrial fibrillation. The hypothetical ablation of all supernumerary AV nodal pathways with short refractory periods resulted in a clinically significant reduction in heart rate in 6% of patients in this population.

Aged↗

[Typical AV nodal reentry tachycardia in 4 anterograde AV nodal pathways. Successful high frequency ablation of slow AV nodal pathways].

CASE REPORT: A 26-year-old patient was referred to our department for electrophysiologic evaluation of recurrent paroxysmal tachycardias with narrow QRS-complexes (< 120 ms). Three jumps in the AV-nodal conduction curve were detected during programmed atrial extrastimulation in sinus rhythm and at a cycle length of 600 ms indicating of 4 antegrade conducting AV-nodal pathways. After intravenous application of orciprenaline an AV-nodal re-entrant-tachycardia (AVNRT) of the common type was induced with a cycle length of 290 ms. During tachycardia, antegrade conduction occurred via one of the slow conducting pathways, retrograde conduction via the fast pathway ("slow-fast"-AVNRT). Application of radiofrequency energy was able to ablate all slowly conducting AV-nodal pathways at one site in the infero-posterior region of Koch's triangle. During control stimulation with and without orciprenaline no AH-jump or inducible tachycardia was found. CONCLUSION: This case shows the rare finding of 4 antegrade AV-nodal pathways in a patient with the common type of AVNRT. Application of radiofrequency current was able to ablate all slow conducting AV-nodal pathways successfully.

Adult↗

Single-chamber versus dual-chamber implantable cardioverter defibrillators: indications and clinical results.

The clinical benefit of standard (single-chamber) implantable cardioverter defibrillator (ICD) therapy in elderly patients or in subjects with moderate or severe heart failure who had ventricular tachyarrhythmias has been debated. We studied the follow-up of 450 patients who underwent standard ICD implantation at our institution in relation to the functional status of heart failure (New York Heart Association Class) or patient's age. During a mean follow-up of 24 +/- 28 months (range, < 1-114 months), 90 patients (23%) died: 9 patients (2%) from sudden arrhythmic death and 5 patients (1%) suddenly, but probably not from arrhythmic causes; 55 patients (14%) died from congestive heart failure and/or myocardial reinfarction and 21 patients (5%) from noncardiac causes. We could clearly demonstrate that ICD therapy was able to prevent sudden cardiac death, both in patients with severely depressed left ventricular function and in patients aged > or = 65 years. An important step forward in ICD technology was the introduction of dual-chamber pacing possibilities to improve left ventricular dysfunction and to allow a more individualized ICD therapy. At our institution, we have implanted a dual-chamber ICD in 15 patients. Preliminary results showed that heart failure improved in 5 patients (33%) and remained unchanged in 10 patients (67%, p = not significant). There were no patients who had a lesser degree of heart failure after implant. Based on our experience so far, in addition to the hemodynamic benefits of dual-chamber ICDs, dual-chamber sensing and wave-form storage capabilities are very helpful and promising diagnostic tools for the detection and handling of inappropriate ICD therapies.

Adult↗

QRS morphologies of the surface ECG of nonsustained ventricular tachycardias during holter monitoring compared with QRS morphologies of spontaneous sustained ventricular tachycardias.

The purpose of this study was to compare electrocardiographic (ECG) morphologies of nonsustained ventricular tachycardias (VTs) during Holter monitoring with the ECG morphology of documented, sustained, monomorphic VTs during the spontaneous event of tachycardia in 14 patients (9 with coronary artery disease), in whom a sustained, spontaneous monomorphic VT had been documented in a 12-lead ECG. All patients had a 24-hour Holter ECG without antiarrhythmic medication. Channel 1 of the Holter ECG was compared with leads V1, V2, and V3, and channel 2 with leads V4, V5, and V6. The Holter ECG of 10 patients in whom the QRS complex during sinus rhythm was similar to the QRS complex in the corresponding ECG leads was accepted for analysis. In 8 of the 10 patients, nonsustained VTs were detected during Holter monitoring. In one of these eight, the ECG morphology of at least one nonsustained VT in the Holter recordings was identical with the sustained VTs. Thus, incidences and ECG morphologies of nonsustained VTs during Holter monitoring do not correlate closely with those of spontaneous sustained monomorphic VTs. Therefore, most ventricular runs during Holter monitoring may have a mechanism different from that of spontaneous sustained VTs.

Adult↗

[Unmasking an exclusively retrograde accessory pathway by catecholamines].

A 52-year-old man with frequent episodes of narrow QRS complex tachycardias with rates of 150/min was admitted for electrophysiological evaluation and treatment. P waves could be seen in the ST-segment of the surface ECG during tachycardia. Atrial stimulation during electrophysiological testing was not able to induce tachycardia. During atrial stimulation, there was no evidence of conduction via an accessory pathway or of dual AV node conduction properties. Ventricular stimulation showed complete ventriculoatrial block. After intravenous administration of the catecholamine orciprenaline, single atrial extrastimuli induced an AV macro-reentrant tachycardia with a rate of 165/min. VA conduction showed the earliest retrograde atrial activation in the left anterolateral area. Thus, there was an accessory pathway which only conducted in ventriculoatrial direction and only during adrenergic stimulation. After successful radiofrequency catheter ablation, complete ventriculoatrial block was recorded even after repeat administration of orciprenaline during ventricular stimulation. This case confirms the need to administer catecholamines in every undiagnosed tachycardia during electrophysiological testing to reveal the mechanism of the tachycardia.

Adrenergic beta-Agonists↗

[Three AV-nodal pathways in a patient with atypical AV-nodal reentry tachycardia].

In a female patient with paroxysmal AV nodal reentrant tachycardias the electrophysiological study revealed three AV nodal pathways. During atrial extrastimulation a sudden AH interval prolongation of more than 50 ms ("break" phenomenon) was observed twice at one basic cycle length. During ventricular extrastimulation a sudden prolongation of the AH interval of the anterograde AV nodal conduction of the induced echo beats was recorded. Three AV nodal pathways were thus present. The atypical form of AV nodal reentrant tachycardia was induced, showing a varying cycle length (290-340 ms). After radiofrequency catheter ablation of the fast conducting beta-pathway, another tachycardia was initiated, now showing a constant cycle length, using the two remaining, more slowly conducting alpha-pathways. One of these was eliminated in another ablation procedure.

Adult↗

Biomagnetic localization of electrical current sources in the human heart with realistic volume conductors using the single-current-dipole model.

The boundary element method was applied in order to investigate the localization accuracy for focal sources measured from MCG data. Various homogeneous volume conductor models were composed: the individually shaped torso, a scaled standard torso, an unscaled standard torso, a scaled cuboid and a scaled ellipsoid. We implemented these models in single-dipole inverse solution techniques. High resolution multichannel data were analysed from two patients showing ventricular extrasystoles and two patients suffering from Wolff-Parkinson-White syndrome. Moreover, we report the localization of shallow- and deep-lying catheters (depth 9 cm and depth 17.5 cm below the measurement grid). Using an individually shaped homogeneous torso yields a localization error of less than 3 cm even for the deepest sources (mean error 2.4 cm). Probability-based dipole localization shows that the remaining error could only partly be explained by data noise statistics. Therefore it seems to be due to either inner inhomogeneities or the inadequacy of the single current dipole or a combination of the two. Thus clinically useful localization accuracy in the millimetre range requires more sophisticated volume conductor and source models. The evaluation of measurement data and simulation study shows that a scaled cuboid model can provide nearly the same localization accuracy as the individually shaped torso model. Single dipole reconstruction with this model is computationally faster than that with the individually shaped model of the human body and is fast enough for use in clinical applications.

Arrhythmias, Cardiac↗